Biotechnology—A New Prospect of Medicine

SHIRLEY, N.Y. - Oct. 20, 2014 - PRLog -- Biotechnology is the use of living systems and organisms to develop or make useful products, or "any technological application that uses biological systems, living organisms or derivatives thereof, to make or modify products or processes for specific use". In simple words, biotechnology is technology based on biology – it harnesses cellular and biomolecular processes to develop technologies and products that help improve our lives and the health of our planet.

Human kind has used the biological processes of microorganisms for more than 6,000 years to make useful food products, such as bread and cheese, and to preserve dairy products. Modern biotechnology is all around our lives. It provides breakthrough products and technologies to cure rare diseases, feed the hungry and protect the environment.

Biotechnology benefits medical care and pharmaceutical industry in an extraordinary fashion. There are more than 250 biotechnology health care products and vaccines available to patients, many for previously untreatable diseases currently.

Creative Biolabs is the leading custom service provider that has extensive experience in various antibody production and engineering fields in biotechnology reign. The service portfolio includes mouse and rat monoclonal antibody production using hybridoma technology, human, monkey, rabbit, chicken, dog, llama and camel monoclonal antibody production using various antibody library technologies [including phage display, bacterial display and yeast display]. It is professional in conducting in depth antibody humanization and affinity maturation using phage display and DNA mutagenesis approaches. Up to now, Creative Biolabs has been making excellent performance in drug discovery and pharmaceutical study including Whole Genome Scanning and Stem Cells study, which was very influential in the industry.

Harvard University genetics researcher George Church, founder of the Personal Genome Project, predicts manufacturers by the end of 2009 will cross the $1,000 threshold, a level at which broad use of the technology would be possible. As the falling of the cost, whole genome scanning is stepping into the era of customization, which means patients have the opportunity to customize their own medical solutions according to their condition. That is a rather gospel for thousands of millions of patients tortured by rare diseases.

For the study of stem cell, as is known to us all, stem cells are potentially to be specialized cells. Researchers could take good advantage of this feature to regenerate medicine that cures life-altering injuries and deadly diseases. Many powerful biotechnology companies are racing to throw their effort to research and develop new drugs for the considerable market profit it brings.

Founded by scientists who are dedicated to the conquering of cancer, it has been devoting to optimizing drug development process, leveraging accessible resources, and forming a team of various background to conduct drug discovery in future.  Creative Biolabs builds up a custom-service-centered business model to deliver the highest quality to clients, search http://www.creative-biolabs.com/aboutus.html for a better solution and better service.